ClosedPublished 5 May 2022

Novartis AG /
AveXis, Inc.

Novartis AG acquired AveXis, Inc., a biotechnology company

Terms
Not stated
Stage
Closed
Buy side: Novartis AG
Buy sideNovartis AG
Source · 5 May 2022
Buy side: Novartis AG
Buy sideNovartis AG
01 / BuyerNovartis AG
02 / TargetAveXis, Inc.
01

What happened

AveXis, Inc. was acquired by Novartis AG in 2018. Sumo Logic, Inc.’s filing identifies AveXis as a biotechnology company.

02

The source

Everything on this page comes from the source below.

01
Source · Source

Novartis AG acquired AveXis, Inc., a biotechnology company

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.